Market Signal Briefing

NEW YORK, Dec. 20, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the “Class Period”), of the important January 9, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased Telix securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Telix class action, go to https://rosenlegal.com/submit-form/?case_id=43778 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 9, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) defendants materially overstated the progress Telix had made with regard to prostate cancer therapeutic candidates; (2) defendants materially overstated the quality of Telix’s supply chain and partners; and (3) as a result, defendants’ statements about Telix’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Telix class action, go to https://rosenlegal.com/submit-form/?case_id=43778   or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

, /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DeFi Technologies, Inc. (NASDAQ: DEFT) between May 12, 2025 and November 14, 2025, both dates inclusive (the "Class Period"), of the important January 30, 2026 lead plaintiff deadline.

So What: If you purchased DeFi Technologies securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do Next: To join the DeFi Technologies class action, go to https://rosenlegal.com/submit-form/?case_id=48771 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 30, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the Case: According to the lawsuit,  defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) DeFi Technologies was facing delays in executing its DeFi arbitrage strategy, which at all relevant times was a key revenue driver for DeFi Technologies; (2) DeFi Technologies had understated the extent of competition it faced from other digital asset treasury ("DAT") companies and the extent to which that competition would negatively impact its ability to execute its DeFi arbitrage strategy; (3) as a result of the foregoing issues, DeFi Technologies was unlikely to meet its previously issued revenue guidance for the fiscal year 2025; (4) accordingly, defendants had downplayed the true scope and severity of the negative impact that the foregoing issues were having on DeFi Technologies' business and financial results; and (5) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the DeFi Technologies class action, go to https://rosenlegal.com/submit-form/?case_id=48771 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

GDX charges a lower expense ratio than SIL and manages over 5 times the assets under management. SIL and GDX both delivered triple-digit one-year returns, but GDX experienced a milder five-year drawdown and stronger long-term growth.

, /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Bitdeer Technologies Group ("Bitdeer") (NASDAQ: BTDR) on behalf of those who purchased or otherwise acquired Bitdeer securities between June 6, 2024, and November 10, 2025, inclusive (the "Class Period"). The lead plaintiff deadline is February 2, 2026.

CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP (KTMC): 
If you suffered losses related to Bitdeer, contact KTMC at:
https://www.ktmc.com/new-cases/bitdeer-technologies-group?utm_source=PR_Newswire&mktm=PR

You can also contact KTMC attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected].

DEFENDANTS' ALLEGED MISCONDUCT:
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about Bitdeer's business, operations, and prospects. Specifically, Defendants misrepresented and/or failed to disclose that: (1) issues with Bitdeer's SEAL04 chip design progress caused a delay in production; (2) Bitdeer decided to take a "dual-track approach" and create two independent designs in an attempt to make-up for its lost progress; (3) despite this, Bitdeer continued to reassure the public that the SEAL04 production and its operations timeline was still on track; and (4) as a result of the foregoing, Defendants' statements about the company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

THE LEAD PLAINTIFF PROCESS:
Bitdeer investors may, no later than February 2, 2026, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP encourages Bitdeer investors who have suffered significant losses to contact the firm directly to acquire more information.

SIGN UP FOR THE BITDEER CASE AT: https://www.ktmc.com/new-cases/bitdeer-technologies-group?utm_source=PR_Newswire&mktm=PR

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP: 
Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including The National Law Journal's Plaintiff's Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group's Honor Roll of Most Feared Law Firms, The Legal Intelligencer's Class Action Firm of the Year, Lawdragon's Leading Plaintiff Financial Lawyers, and Law360's Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com. 

CONTACT:
Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
[email protected] 

May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.

SOURCE Kessler Topaz Meltzer & Check, LLP

The AI software powerhouse's share price has risen by 585% over the past five years.

In recent months, rumors have circulated that artificial intelligence (AI) powerhouse Palantir (PLTR +4.14%) might be preparing to announce a stock split. Why should investors care? While stock splits technically do not directly affect returns in and of themselves, time and again, split announcements are followed by rallies.

Today's Change

(

4.14

%) $

7.69

Current Price

$

193.38

But do splits actually cause rallies? It's unclear. It may just be that splits are generally announced by companies when they already have strong momentum behind their stocks, and any link between the two things is correlative. It's also possible that the reduced share prices attract new investors who would not otherwise have invested in those stock-splitting companies.

The rumors weren't true, but that doesn't mean a split isn't coming
The most recent buzz about a Palantir stock split can be traced back to an RBC Capital analyst who said that retail traders were "focused on the potential for a stock split," hoping it would be announced along with the company's Q3 earnings in November. While no split was announced at that time, after the stock's meteoric 585% rise over the last five years -- and given the stock's popularity with the type of retail traders who tend to respond particularly favorably to splits -- I wouldn't be surprised if one occurs in the next year.

Image source: Getty Images.

Palantir shares are pricey
Whether a split happens or not is beside the point, really. While rallies often follow splits, they can be short-lived if the underlying business fails to justify the higher price with its performance. While I think Palantir will continue to rapidly grow its top and bottom lines for some time, I still wouldn't buy the stock. Not at this price. As of Thursday, it was trading at a price-to-earnings ratio of about 435, and even its 1-year forward P/E ratio was 184. Those are extremely lofty premiums. As such, the company is priced for perfection, and any wavering would likely lead to a major correction.

Johnny Rice has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool has a disclosure policy.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of AWP, MPW, AND TPVG either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Beyond Saving, Philip Mause, and Hidden Opportunities, all are supporting contributors for High Dividend Opportunities. Any recommendation posted in this article is not indefinite. We closely monitor all of our positions. We issue Buy and Sell alerts on our recommendations, which are exclusive to our members.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

RADNOR, Pa., Dec. 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against StubHub Holdings, Inc. (“StubHub”) (NYSE: STUB) on behalf of those who purchased or otherwise acquired StubHub common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Offering Documents”) issued in connection with StubHub’s September 2025 initial public offering. The lead plaintiff deadline is January 23, 2026.

CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:
If you suffered StubHub losses, contact KTMC at: https://www.ktmc.com/new-cases/stubhub-holdings-inc?utm_source=Globe&mktm=PR

You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected].

DEFENDANTS’ ALLEGED MISCONDUCT:
The complaint alleges that, in the Offering Documents, Defendants made false and/or misleading statements and/or failed to disclose that: (1) StubHub was experiencing changes in the timing of payments to vendors; (2) those changes had a significant adverse impact on StubHub’s free cash flow, including trailing 12 months free cash flow; (3) as a result, StubHub’s free cash flow reports were materially misleading; and (4) that, as a result of the foregoing, Defendants’ positive statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

YouTube Video: https://youtube.com/shorts/OdXl5OZsZXE?feature=share

THE LEAD PLAINTIFF PROCESS:
StubHub investors may, no later than January 23, 2026, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.  The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP encourages StubHub investors who have suffered significant losses to contact the firm directly to acquire more information.

SIGN UP FOR THE STUBHUB CASE AT: https://www.ktmc.com/new-cases/stubhub-holdings-inc?utm_source=Globe&mktm=PR

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:

Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
[email protected]

May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.

Centrus Energy is up over 218% on the year. Before you buy, here are two essential things to know.

Centrus Energy (LEU +13.97%) is a U.S.-based uranium enricher and nuclear fuel supplier.

The company makes money by supplying uranium fuel, as well as performing contract work, like its recent demonstration of high-assay, low-enriched uranium (HALEU) for the Department of Energy (DOE).

If that doesn't sound exciting to you, consider this: With the U.S. trying to reduce reliance on Russian nuclear fuel, Centrus has gone from a mostly obscure nuclear supplier to an essential component in a nuclear supply chain.

Still not exciting? How about this: The stock has gained over 218% on the year (as of writing). At one point in mid-October, it had grown fivefold on the year, before sinking with nuclear stocks more broadly.

If that has piqued your interest, here are two other things investors should know.

1. Centrus is a strategic asset for the U.S. government
Centrus' biggest advantage is its uniqueness. It's one of the only U.S.-owned, publicly traded uranium enrichers. It was also the first U.S. company to hold a license to produce HALEU, a higher-assay nuclear fuel that many next-generation reactors are expected to use.

That detail matters. For years, much of the world's enrichment capacity has belonged to just a few countries, with Russia being the most dominant. If advanced reactors become part of the future power mix for the U.S., including as a potential source of reliable electricity for data centers, shoring up a HALEU supply chain would be a priority.

Image source: Centrus Energy.

Indeed, the DOE is already working closely with Centrus to help expand its HALEU production. In simple terms, it's paying Centrus to run a HALEU production demonstration in Piketon, Ohio, and to deliver HALEU to the government. Centrus has already hit a major milestone under that agreement by delivering 900 kilograms of HALEU, and the DOE has extended its contract for another 900 kilos in 2026.

2. Finances are strong, but don't expect every quarter to be smooth
Centrus is already profitable, which sets it apart from other speculative nuclear stocks, like Oklo and Nano Nuclear Energy.

In the third quarter of 2025, Centrus posted roughly $4 million in net income on about $75 million in revenue.

Both were lower than its second quarter, which saw net income of about $29 million on roughly $155 million in revenue. At the same time, Centrus' contracts don't generate steady, quarter-by-quarter revenue, and earnings can swing depending on pricing when customers take delivery.

LEU Revenue (Quarterly) data by YCharts

Centrus' balance sheet is also strong. After raising about $805 million through a convertible note deal in August, the company ended its third quarter with about $1.6 billion in unrestricted cash. That gives it exceptional flexibility for a business of its size, especially as it prepares to expand its enrichment plant in Piketon, Ohio.

The trade-off, however, is those same notes could turn into new shares later, which would dilute existing shareholders.

Is Centrus a buy?
Centrus makes sense for patient investors who can stomach volatility and believe in a long-term nuclear revival. It's not, however, a safe, steady stock. For those who want more predictability, a nuclear energy exchange-traded fund (ETF) might be better suited.

C3 Metals Inc (TSX-V:CCCM, OTC:CUAUF) CEO Dan Symons talked with Proactive about the company’s encouraging results from its first-ever drill hole at the Khaleesi target in southern Peru.

The Khaleesi project lies around eight kilometres west of the company’s existing Montaña de Cobre resource, which hosts 52.0 million tonnes at 0.5% copper and 0.2g/t gold.

Symons explained that this first hole intercepted 269 metres at 0.3% copper with by-product credits of gold, molybdenum, and silver.

The hole also passed through a magnetite skarn zone, increasing the grade by 37% to 0.41% copper over a 60-metre interval.

Proactive: Really exciting results out of the first ever drill hole at Khaleesi. We'll talk about some of the results in just a second, but maybe remind everyone a little bit about Khaleesi and what this drill program is doing.

Dan Symons: Absolutely. Khaleesi is a brand new discovery about eight kilometres west of our existing Montaña de Cobre resource, where we have 52 million tonnes at 0.5% copper and 0.2g/t gold. That equates to 570 million pounds of copper and 326,000 ounces of gold in a pit-constrained resource. We discovered Khaleesi while expanding our land position to the west. We now hold 310km².

We're a junior among the giants on this belt — we're less than 45km from MMG’s Las Bambas and Hudbay’s Constancia mines. Further southeast, there’s Glencore’s Antapaccay and Freeport’s Cerro Verde, their second-largest producer. It’s a world-class, copper-producing belt, and we have one of the largest junior positions.

You had a geological model of what you wanted to look at. What are you most happy about in this particular hole — the identification, the grades, the widths?

If this hole had been drilled at any of the other producing mines on the belt, it would be in the mine plan. These are big tonnage targets — over a billion tonnes in many cases. We intercepted 269m at 0.3% copper, with by-product credits of gold, molybdenum, and silver. Downhole, we hit a magnetite skarn zone, and the grade increased by 37% to 0.41% over 60m. That was deeper, but important.

On the western side, we have a skarn, and on the eastern side a batholith with porphyry-style mineralisation. In the middle, there’s glacial till — it’s blind. We used geophysics to drill under that till, and our first hole extended mineralisation by at least 100m under it. That means it’s wide open and the target and tonnage potential are significantly increased at Khaleesi.

You’re doing 6,000 metres in this program. Are you changing the plan or sticking to a direction?

As you get visual information — and with copper you can often see mineralisation — you make tweaks. For example, this hole passed through a garnet skarn, then barren diorite, then back into garnet skarn, and finally into magnetite skarn, which is a very receptive host. That’s where we saw the highest grades.

Now we know that the magnetite skarn sits under the glacial till, we can drill a shallow hole across it and potentially extend the mineralisation 200m closer to surface. That could reduce strip ratios and capex in future mine planning. So, yes, we adjust as we go.

Lastly, when you’re at this early stage — just one hole — are you thinking about potential already?

Yes. Before we drill a single hole, I always ask the geologists what our tonnage target is. You need to know what grades will make it economic. Tonnage can change quickly with drilling, but if the target holds together, you then ask what grade is needed.

We think about economics from day one. Our target is based on mapping, surface alteration, soil and rock geochemistry, and geophysics. It’s a very large target. We’re pleased with this first hole. We have eight holes completed now, so more news is coming.

Quotes have been lightly edited for clarity and style

Taiwan Semiconductor is positioned to thrive in 2026.

Finding the ultimate stock to buy for 2026 is no easy task. First, you have to address whether the stock will come from an AI-related field or not. There are growing fears of an AI bubble forming, but those fears are negated by real money being spent by the AI hyperscalers, who are racing to build out as much computing capacity as possible. I think one of the best stocks to buy for 2026 comes from this industry, and it's a key supplier.

While I'll entertain an argument of whether Nvidia's dominance is slipping, what isn't up for debate is how much is being spent on AI infrastructure. After setting records in 2025, the AI hypercalers look to be setting a new record on data center capital expenditures again in 2026. There are several companies positioned to take advantage of that buildout, but none is in a better spot than Taiwan Semiconductor Manufacturing (TSM +1.67%).

Image source: Getty Images.

Taiwan Semiconductor is a neutral party in the AI arms race
Taiwan Semiconductor is a chip fabrication business and sells its production capacity to various companies in the chip realm. Taiwan Semiconductor is regarded as the top company in its industry, which is why nearly all of the major computing unit designers partner with Taiwan Semiconductor. It doesn't matter if the computing unit being purchased is from Nvidia, Advanced Micro Devices, or Broadcom; chances are, it has a chip from TSMC in it.

This places Taiwan Semiconductor in a neutral position, as it benefits from increased spending regardless of which computing unit is the most popular. The trends are clearly in favor of increased data center spending, and that trend isn't expected to slow down anytime soon.

Today's Change

(

1.67

%) $

4.76

Current Price

$

289.44

Nvidia believes that the global data center capital expenditures will rise from $600 billion in 2025 to $3 trillion to $4 trillion by 2030. Not all of that money will flow toward computing, as there are also construction and land costs to consider. AMD offered a similar projection, as they believe the compute market will be worth $1 trillion by 2030. This bodes well for Taiwan Semiconductor, as it will be providing the chips to power most of these data centers.

However, one issue that may hamper the growth of the industry is power capacity. It's no secret that we could be headed for an energy shortage in the near future, and doing everything possible to consume less energy to maximize computing performance is critical.

Taiwan Semiconductor understands this, which is why its latest technology is focused on improving energy consumption. Its next generation of chips, 2nm (nanometer), promises to consume 25% to 30% less energy when configured for the same speed as its 3nm predecessor. That's a huge jump in efficiency, and may be what's needed to keep the AI buildout going.

These chips are entering production right now and will boost Taiwan Semiconductor's finances throughout 2026. However, Taiwan Semiconductor is also doing incredibly well right now.

TSMC provides incredible performance at a low price
In its most recent quarter, Taiwan Semiconductor's revenue rose at a 41% pace in U.S. dollar terms, placing it among the fastest-growing big tech stocks. With the AI buildout not expected to slow down anytime soon, Taiwan Semiconductor should be able to keep this growth rate up for several years.

Despite its strong growth, the stock really doesn't have a premium price tag assigned to it.

TSM PE Ratio (Forward 1y) data by YCharts

At 23 times next year's earnings, Taiwan Semiconductor doesn't carry a premium price tag. It is priced lower than its peers, with AMD trading at 32 times next year's earnings, Broadcom at 25, and Nvidia at 24.

Taiwan Semiconductor is reasonably priced and is slated to deliver impressive growth over the next few years. As a result, I think it's the ultimate stock to buy now, as it's set to benefit regardless of which computing unit the AI hyperscalers are using. All it needs to succeed is for the AI hyperscalers to continue spending heavily, and they are primed to do just that.

Keithen Drury has positions in Broadcom, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool has positions in and recommends Advanced Micro Devices, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy.

Both SCHQ and VGLT charge the same ultra-low expense ratio and focus on long-term U.S. Treasury exposure. VGLT offers far greater assets under management, while SCHQ is newer and smaller.

The premium athleisure brand lost its shareholders a significant sum of money in 2025.

Lululemon Athletica (LULU 2.63%) shareholders are ready to forget about 2025. As of Dec. 16, the consumer discretionary stock is down a gut-wrenching 46%. Investors that bought an S&P 500 index fund would've witnessed their money grow 17%. That underperformance is startling.

As we think about Lululemon in 2026, here are the three most important things that investors need to watch.

Image source: Getty Images.

Demand in the U.S. needs to pick up
The U.S. is Lululemon's biggest market, as it represented more than half of the company's revenue in the third quarter of 2025 (ended Nov. 2). Having a strong position in a country whose citizens have tremendous buying power is what every consumer brand seeks. However, things haven't been going too well lately.

I suspect one of the main reasons Lululemon shares have been under so much pressure is because demand in the U.S. has been lackluster. Sales in this country declined 3% year over year in the third quarter. At the same time, the Chinese market registered an explosive 46% gain.

Lululemon is hopeful that a focus on introducing fresh product assortments can reignite customer interest in the world's largest economy.

Lululemon must maintain its brand position
It's difficult to find lasting success in the apparel industry. There's so much competition from rivals across the board. And consumer preferences are always changing, which can be hard to predict for even the most seasoned industry executives. Lululemon stands out because it has built a leading position in the market thanks to its powerful brand recognition, known for premium merchandise that has historically commanded pricing power.

This is exemplified by Lululemon's gross margin, which continues to be impressive, coming in at 55.6% in Q3. That's significantly higher than industry stalwart Nike (gross margin of 42.2%). It's also better than consumer tech giant Apple's product gross margin of 36%.

Lululemon's success in 2026 and over the long term depends on the brand maintaining its relevance. This comes down to product innovation and having the right marketing strategies in place.

Today's Change

(

-2.63

%) $

-5.66

Current Price

$

209.45

A new CEO is on the way
When Lululemon reported its latest financial results, the business announced that Calvin McDonald, CEO since 2018, will be stepping down at the end of January 2026. Meghan Frank, chief financial officer, and André Maestrini, chief commercial officer, will be interim co-CEOs after McDonald's departure until a replacement is found.

Anytime there's a leadership change without a successor already picked out, it introduces uncertainty. Investors will want a new CEO who has the right experience to lead the business. And it's important that this person clearly explains what the strategic priorities are to jump-start Lululemon's revenue growth. This will help the company gain the market's confidence.

Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Apple, Lululemon Athletica Inc., and Nike. The Motley Fool has a disclosure policy.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of REGN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

All investment opportunities carry inherent risk, including potential loss of principle. Carefully consider your investment objectives, level of experience and risk appetite before making any investment. The above discussion is a framework for investors (both long and short), to understand the factors that will move the underlying security’s price. It is not a prediction and should not be considered investment advice. The author is long REGN and may add to the position by purchasing additional shares.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

BOLTS Technologies CEO Yoon Auh explains that the world sees quantum computing as an "undeniable advantage" for tech that carries the risk of breaking the blockchain. He makes the case that the technology is bearish for crypto and that regulation needs to be put in place to prevent irreversible damage.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In James Hardie (JHX) To Contact Him Directly To Discuss Their Options

If you purchased or acquired James Hardie common stock during the period from May 20, 2025 through August 18, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.

Click here to participate in the action.

NEW YORK, Dec. 20, 2025 (GLOBE NEWSWIRE) --

What’s Happening?

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE:JHX) in the United States District Court for the Northern District of Illinois on behalf of all persons and entities who purchased or otherwise acquired James Hardie common stock between May 20, 2025 and August 18, 2025, both dates inclusive (the “Class Period”).Investors have until December 23, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
What are the Allegation Details?

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) James Hardie's key North America Fiber Cement segment was experiencing weakening demand due to distributor inventory destocking known to the Company by April and early May 2025; and (2) despite this knowledge, the Company falsely represented that demand remained strong and that inventory levels were “normal”; and (3) on August 19, 2025, James Hardie revealed a 12% sales decline in the segment, attributing it to “normalization of channel inventories,” and warned of continued weakness; and (4) following this news, the Company's share price dropped more than 34% thereby damaging investors. What are the Next Steps?

If you purchased or otherwise acquired James Hardie shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
[email protected]
www.bespc.com

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Blue Owl To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Blue Owl between February 6, 2025 and November 16, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

NEW YORK, Dec. 20, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) and reminds investors of the February 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that Blue Owl was experiencing a meaningful pressure on its asset base from BDC redemptions; (2) that, as a result, the Company was facing undisclosed liquidity issues; (3) that, as a result, the Company would be likely to limit or halt redemptions of certain BDCs; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On November 16, 2025, the Financial Times published an article describing how "Blue Owl has blocked redemptions in one of its earliest private credit funds as it merges with a larger vehicle overseen by the asset manager in a deal that could leave investors with large losses."

According to the report, Blue Owl Capital Corporation II investors are restricted from pulling money from the fund until a recently announced merger with Blue Owl Capital Corporation closes in early 2026.

The article further explains how, once the merger occurs, investors in Blue Owl Capital Corporation II will permanently lose the ability to redeem cash at the fund's Net Asset Value (NAV). Instead, investors will trade their shares in for the publicly traded Blue Owl Capital Corporation shares, which are currently trading approximately 20% under the fund's NAV.

On this news, Blue Owl's stock price fell $0.85, or 5.8%, to close at $13.77 per share on November 17, 2025, thereby injuring investors.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Blue Owl’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Blue Owl Capital class action, go to www.faruqilaw.com/OWL or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2fceea32-072d-4e7c-b9fd-7ceadbf788ad

Pinnacle Silver & Gold Corp (TSX-V:PINN, OTCQB:PSGCF) CEO Robert Archer talked with Proactive about the company's first drill program at the El Potrero project in Mexico, a unique initiative starting with underground drilling rather than surface work.

Archer explained that the underground access available at El Potrero, due to historic mining that ceased 35 years ago, gives the company immediate access to mineralized zones.

However, he pointed out the current workings are limited in extent, and only sampling what's visible on the walls and ceilings leaves uncertainty about the broader potential.

Proactive: You're about to start Pinnacle's first drill program at El Potrero. And it's underground rather than surface drilling. Why is that significant? And what does it tell investors about the stage of this project?

Robert Archer: Yeah. Hi. Great to be back on the show. It is quite unusual for a first program on a project to be underground. Many projects don't have underground access like we do, so that’s been quite significant. Because of previous activity there — it was in production 35 years ago — we have underground workings that provide access right into the mineralized zone. However, those workings are somewhat limited in extent. You can only sample what's exposed on the walls and maybe the ceiling, so we don't know what lies beyond. That’s where the drilling comes into play — to understand size, grade distribution, and the shape of the mineralized zones.

Sampling so far has returned very high gold and silver grades. What’s the key question this drilling is designed to answer that sampling can’t?

It’s really about the extent of the mineralization. We’ve seen some grade variability. I don’t want to use the word nugget effect — we’re not seeing coarse gold — but the mineralization is within a breccia zone, which tends to be inconsistent in texture and content. So, we’re trying to understand the grade distribution better. That helps with future mining because you want to blend high and low grades for a consistent feed to the plant. So it’s all about grade distribution and understanding the size and shape of the mineralized zones — things the existing workings can’t tell us.

You’ve described this as more delineation than exploration drilling. What would a successful outcome from the 12-hole program look like in practical terms?

It should delineate the three zones that we know of within the three mines. That said, we don’t know what lies between those mines — there’s about 120 metres between two of them, and another 150 metres left unexplored on the other side. Those gaps will need to be drilled from surface. But the underground drilling should give us enough of an understanding to start putting together a preliminary mine plan — including head grade and our technical and mining approach.

And once the program's complete, what are the next technical and corporate milestones investors should be watching as we head into 2026?

The surface drill program will follow the underground one. That will focus more on exploration, targeting new zones between existing workings and veins like El Capulin and La Estrella, which have never been drilled before. Neither has Dos de Mayo. These are new veins that we know have mineralization — we've sampled them at surface — but we need to determine extent, continuity, and grade.

Quotes have been lightly edited for style and clarity

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

NEW YORK, Dec. 20, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) and reminds investors of the January 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose key facts about Inspire V, including the actual market demand for the device and whether the company had taken the steps necessary to successfully launch it. Defendants issued a series of materially false and misleading statements that led investors to believe demand for Inspire V was strong and that Company had taken the necessary steps for a successful launch.

On August 4, 2025, Inspire Medical Systems announced significant setbacks in the launch of its new Inspire V device. The company revealed that the rollout was taking much longer than expected because many treatment centers had not yet completed the required training, contracting, and onboarding needed to begin using the product. Inspire also disclosed billing and reimbursement challenges, explaining that although Medicare had approved a CPT code for Inspire V, the necessary software updates for claims processing did not go into effect until July 1. As a result, implanting centers could not bill for procedures before that date and instead continued using the older Inspire IV system.

In addition to these logistical and reimbursement problems, Inspire reported that the Inspire V launch was suffering from weak demand and excess inventory. These issues forced the company to sharply cut its 2025 earnings guidance by more than 80%. Following these revelations, Inspire’s stock price fell more than 32% in a single day—from $129.95 per share on August 4, 2025, to $87.91 per share on August 5, 2025—wiping out approximately $1.2 billion in market capitalization.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.  

Faruqi & Faruqi, LLP also encourages anyone with information regarding Inspire Medical’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Inspire Medical class action, go to www.faruqilaw.com/INSP or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2fceea32-072d-4e7c-b9fd-7ceadbf788ad

Plug Power stock has performed poorly over the past few years, but that could change soon.

If you're looking for a stock that will provide stability and remove volatility from your portfolio, turn around now. Plug Power (PLUG 2.88%) is not for you. Plug Power, an industry leader in hydrogen fuel cell technology, is truly only suitable for investors with a longer time horizon and those who have the stomach for high-risk, high-reward stocks.

Today's Change

(

-2.88

%) $

-0.07

Current Price

$

2.19

A rocky road for Plug
Plug Power stock has performed poorly for investors in the past five years, losing more than 90% of its value in the past half-decade as of Dec. 16. That could change in the coming years, however. Plug recently secured outside capital and now has enough runway to stay the course on its mission to produce an end-to-end hydrogen ecosystem.

Image source: Getty Images.

If Plug is successful in capturing the hydrogen market from generation to storage and delivery, the return on a $1,000 investment could be spectacular. It's estimated that the green hydrogen market could be worth as much as $74 billion by 2032.

Plug's revenue is growing, and the company generated $484.7 million through the first nine months of 2025. The operating losses are adding up, too, though, and that's where investing in Plug is tricky. The company needs to focus on reducing cash burn and continuing to further its global reach to succeed in the coming years.

The hydrogen market is heating up
A $1,000 investment in Plug Power today is really only worth it if you believe the hydrogen market is going to reach its full potential. The bull case is that if any company is positioned to capture a considerable portion of the market share, it's Plug Power. It's proven itself commercially viable, deploying more than 72,000 fuel cell systems and 275 fueling stations around the world. Plug is also partnered with major companies such as Walmart, Amazon, Home Depot, BMW, and BP, giving it a leg up on competitors.

The bear case is that if hydrogen demand is weaker than anticipated or if Plug fails to control costs, the fuel cell maker will eventually run out of energy.

Catie Hogan has positions in Plug Power. The Motley Fool has positions in and recommends Amazon, Home Depot, and Walmart. The Motley Fool recommends BP and Bayerische Motoren Werke Aktiengesellschaft. The Motley Fool has a disclosure policy.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of AMT, CTRE, REG, DGRO, XLU, AHR, CDL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Ilika PLC (AIM:IKA, OTCQX:ILIKF) earlier this week announced the shipment of its M300 prototype solid-state batteries to customers. The company said this represents a key commercial milestone in its development roadmap.

The M300 units are miniature solid-state batteries designed for use in active implantable medical devices. Ilika said potential applications include neurostimulators, sensors, smart orthopedic and orthodontic implants, and devices used in ophthalmology.

The company described the innovation as part of the broader shift toward electroceuticals, where electronic implants could replace certain pharmaceuticals. Ilika highlighted that this could offer advantages by reducing the risk of side effects. It said neurostimulators, for instance, are used for pain relief without the addiction risks associated with pain medication.

CEO Graeme Purdy joined the Proactive studio to tell us more.

Proactive: Graeme, good to see you again. How are you?

Graeme Purdy: Hey, Steve. Good to speak to you again. Very well, thank you.

Proactive: Good. Well, excited because you've got significant news out for the company. In fact, a real major milestone for Ilika. I'll let you take it from there. Graeme, tell everyone what you're very excited about today.

Graeme Purdy: We've started shipping M300 prototypes to customers. This is a really important commercial milestone for us. We've been working hard together with our manufacturing partner, Cirtec Medical, and we've been able to initiate those deliveries just in time for Christmas.

Proactive: Let's tell everyone about the M300 prototypes. What are they, what do they do, and why are they so significant?

Graeme Purdy: These are miniature batteries developed for active implantable medical devices. They’re designed for a range of applications, including implanted sensors, neurostimulators, smart orthopedic implants, orthodontics, and ophthalmology devices.

Proactive: So people understand, this is really the future of where medical is going. You're on the cutting edge of where things are heading in the medical world.

Graeme Purdy: That’s right. Some people refer to this as the electroceutical revolution. The idea is that these implants can replace pharmaceuticals, and they offer advantages because they don't carry the same side effects. For instance, neurostimulators are often used for pain relief, but strong pain-relieving drugs can come with addiction issues. If you can come up with an alternative, you've got a significant advantage.

Proactive: You mentioned Cirtec. Just want to get a comment from you on them. I know you signed this ten-year manufacturing agreement. From where that was to where you are today, I imagine you're pretty happy with that agreement and the work you do together.

Graeme Purdy: Absolutely. I think they’ve been exactly the right partner for us. They’ve got a great reputation as a manufacturer of medical devices, strong customer relationships, and they’re already delivering quality product to a lot of the target and order book customers we’ve identified for these Stereax batteries.

Proactive: Yeah, 21 of them in fact—21 customers. I thought it'd be a good opportunity, Graeme, also to get a comment on 2026. You've hit this milestone as the year ends, so what should people be expecting next year?

Graeme Purdy: We're going to ramp up production. These initial prototypes will go through an enhancement process, and we'll begin work on the roadmap for additional types of miniature solid-state batteries.

Proactive: Congratulations on this milestone. Sounds like it's going to be an exciting 2026. Graeme, thank you so much. Good to see you again. We'll talk soon.

Graeme Purdy: It's been a pleasure. Thank you.

watch now

Lucid Motors gets rave reviews from critics. But it's sorely lacking customers.

That's a problem the company can't afford.

The Arizona-based EV maker has top-shelf tech, deep-pocketed backers, and highly praised cars. However, it has struggled to meet production targets, and has been unable to steal the spotlight away from established luxury brands with century-old pedigrees.

Lucid is ramping up production of its high-end, three-row, Gravity SUV, though it has sold only a few hundred units so far in 2025. The Gravity's production ramp has faced a slew of challenges, primarily supply chain shortages.

Yet the company already has plans for another vehicle aimed more at the middle of the market, where it would compete with the top-selling Tesla Model Y SUV. And it's investing in self-driving cars for consumers while working on a robotaxi fleet with Uber and self-driving tech maker Nuro.

In the process, Lucid is burning through a lot of money. The company's third-quarter results were worse than Wall Street expected, with a net loss of close to $1 billion.

"Their gross profit has been getting kind of worse," said Tom Narayan, an analyst at RBC Capital Markets. "A lot of people are doing the math. How long can the company keep losing cash?"

Adding to its challenges is a tougher environment for all EV manufacturers. Demand has fallen short of expectations, and many automakers are pulling back. EVs have lost key support from the federal government, including a $7,500 tax credit, funding for charging, and restrictions on state level programs that incentivize automakers to produce zero-emission vehicles.

A 'fantastic car'Lucid's first vehicle, a sedan call the Air, is the most popular vehicle in its segment, according to Cox Automotive. Through the third quarter, it was the third best-selling full-size luxury sedan, and the top selling electric one, according to the company. The Air is frequently a "critic's pick." No other EV can touch the 512-mile range of the Air Grand Touring, one of its top trim levels.

Last year, Lucid delivered 10,241 vehicles, the majority of which were Air sedans, a 71% increase from 2023. U.S. EV leader Tesla delivered 1.8 million.

Unfortunately, sedans have consistently compared to SUVs, crossovers, and pickups--which now all but dominate the roads. Of the top 10 best-selling models in the U.S., seven are from those three segments, according to Edmunds.

"It was a fantastic car," said Sam Abuelsamid, vice president of market research for Telemetry. "It still is a fantastic car. But it came to market at kind of the wrong time."

In 2023, Tesla's Model Y was the best-selling vehicle in the world, according to JATO Dynamics. It sold more than 265,000 units in the U.S. through the third quarter of 2024, according to Cox Automotive, about 100,000 more than the Model 3 sedan. Among EVs, the Model 3 is unusually popular for a sedan. Behind the two Tesla Models, the three vehicles that round out the top five are crossovers — Chevrolet Equinox, Ford Mustang Mach-E and Hyundai Ioniq5.

The Model S, the Air's closest Tesla competitor in terms of size, performance, and price, sold just over 4,500 units in the same period.

The highest volume EVs, such as the Model Y, are also less expensive than the Air, which starts just above $70,000 and runs up to about a quarter of a million dollars. The Model 3 is nearly half that. The average EV transaction price in November was just above $59,000, according to Cox Automotive.

"There's just not enough of a market for those premium electric sedans right now," Abuelsamid said.

Lucid sold slightly more than 300 Gravity SUVs in the US through the third quarter of 2025, according to Cox Automotive. Like the Air, the Gravity has a high price tag. Nevertheless, the company has said the Gravity stands to attract six times as many customers as the Air.

"We'll see if that's the case," said Narayan. "The latest numbers I've seen show it kind of equalizing the sales of sedans."

Lucid interim CEO Mark Winterhoff told CNBC in an interview that the company has seen "a very good uptick in demand when it comes to the Gravity as compared to the Air." He added that most customers are configuring the car in ways that run the price up above $100,000.

Production troubleDemand might be strong, but Lucid also has to get the vehicle into customers' hands. Gravity's launch earlier in 2025 was beset by shortages of key materials like magnets, aluminum, and chips, Winterhoff said on the company's third-quarter earnings call.

"We haven't been able to produce as many as we wanted up until this point," Winterhoff told CNBC. "We're very confident right now that we solved those problems."

Deliveries have risen for seven straight quarters, culminating in a 47% percent jump over the third quarter of 2024. Lucid has added a second shift to the final assembly section of its factory to meet demand.

The company said demand has been resilient despite worries the EV market is stalling after the federal EV incentive ended on Sept. 30.

"In October, our delivery numbers went up," Winterhoff said. "Whereas in many other pure EV players or even EVs for incumbent players that also have [internal combustion] vehicles, the deliveries dropped down drastically."

watch now

Still, analysts say it's a tougher time to make EVs than it was when Tesla was ramping up the Model 3 and Model Y.

"They were the only game in town," Narayan said. "So there wasn't competition there. They also benefited from battery prices falling significantly. And they got a lot of government support. Today we're in a very different world." 

If gross profit does keep getting worse, the company will eventually have to return to investors, Narayan said. Lucid is currently about 55% owned by the Saudi Public Investment fund, according to FactSet.

In the third quarter, Lucid and the PIF agreed to increase a delayed draw term loan credit facility from $750 million to roughly $2 billion. A DDTL is a loan the company can draw on over time, rather than all at once. That brings its total liquidity to $5.5 billion. The company has said it has enough to get through the first half of 2027.

"So far, the Saudis have put many billions of dollars into Lucid, and they've been very patient through Lucid's struggles as they try to ramp up production and sales," said Abuelsamid. "It's unclear how long they will continue to be patient."

The company also received a $300 million investment from Uber in September to develop a platform for robotaxis with a third partner, autonomous driving tech developer Nuro. On top of that, Uber plans to buy 20,000 Gravity vehicles for the self-driving fleet.

Separately, Lucid has a partnership with Nvidia to develop what it calls the "the first true eyes-off, hands-off, and mind-off (L4) consumer owned autonomous vehicle." L4 means Level 4, nearly the highest level of autonomy in the current system devised by the Society for Automotive Engineers.

"You need to invest first and then you reap the benefits later on," Winterhoff said. "And therefore we have to do a lot of things in parallel."

Smaller SUV on the wayDespite Gravity's production challenges, the company is already at work on its next vehicle — a mid-size crossover priced closer to the industry average of about $50,000.

This could boost volumes, but deepen losses.

"If gross profit is negative at a vehicle transacting around $100,000 or more on average, what Lucid's Air and Gravity are currently going for, what will it look like when the company is selling a vehicle that is closer to half of that?" Narayan said.

"One answer could be, well, it's a much bigger scale, so you have better operating leverage," Narayan said. The argument, he said, is that Lucid's technology enables it to squeeze a lot more range out of a battery than competitors.

"Our vehicles are way more efficient by 30% to 40% than the competition, which means smaller battery use smaller battery to achieve the same range," said Emad Dlala, senior vice president of engineering and digital at Lucid. "That means a lower [bill of materials] cost. That means better margins."

Dlala said the Lucid Air Pure has a battery size of a Tesla Model Y, but has a range of 420 miles, about a hundred miles more than the Tesla Model Y.

Lucid says the money it's spending goes to developing an array of technologies and manufacturing processes that are hard to copy.

"Lucid has about over 10 years of powertrain history," Dala said. "This didn't come overnight. There's lots of IP patented technologies across powertrain, vehicle and software," which lead to "gains in efficiency across the board," he said.

That even extends to the way the cars are made.

"We use manufacturing processes here that no one else in the industry uses in powertrain," said Adrian Price, senior vice president of operations at Lucid.

"Lucid is very highly vertically integrated," he said, meaning it brings much of the car-making process in house. "We have a lot more of our own subassemblies. That's also how we get the performance that other people don't. A lot of that engineering is outsourced by other major automakers. Not only do we do the engineering, but we also do the manufacturing, and we can control some of the Lucid secret sauce by doing it in-house."

One area where Lucid appears to lag competitors is brand awareness.

"A lot of people don't know what Lucid is," Narayan said. "That's the biggest, I think, hurdle that they have."

The company has given more thought to marketing, and raising its profile in the luxury market, where it's going up against names like Mercedes-Benz, Porsche, and BMW.

"The buyer of a luxury brand, typically, they like things like heritage," Narayan said. "The brand matters. So, you know, how do you create that from scratch?"

"We are very well known and have tons of accolades in the motor press, Winterhoff said. "So everybody who's interested in cars knows about it. But that's not the majority of vehicle buyers."

So, it has begun a new marketing and advertising strategy for the Gravity, with Hollywood actor Timothee Chalamet as its first "global brand ambassador."

"We're shifting from focusing on our vehicles, about the capabilities of our vehicles, to what does it mean to own a Lucid and what does it say about you?" Winterhoff said.

Winterhoff said he's confident the company can successfully ramp the Gravity, while building and eventually delivering its mid-size vehicle.

"That is the point where I think this is a sustainable business going forward," he said. "We have a clear plan also to profitability."

Watch the video to get an exclusive inside look at Lucid's Gravity production and to find out what's next for the automaker.

Company: LKQ Corp. (LKQ)Business: LKQ engages in the distribution of replacement parts, components, and systems used in the repair and maintenance of vehicles and specialty vehicle aftermarket products and accessories. The company operates through four segments: wholesale-North America, Europe, specialty, and self service. It offers bumper covers, automotive body panels, and lights, as well as paint and paint-related consumables for refinishing vehicles; mechanical automotive parts and accessories; salvage products, including mechanical and collision parts comprising engines; transmissions; door assemblies; sheet metal products, such as trunk lids, fenders, and hoods; and lights and bumper assemblies. The company also provides scrap metal and other materials to metals recyclers; precious metals contained in certain of our recycled parts, such as catalytic converters; and brake pads, discs and sensors, clutches, steering and suspension products, filters, and oil and automotive fluids, as well as electrical products. It serves collision and mechanical repair shops, and new and used car dealerships, as well as retail customers. LKQ was incorporated in 1998 and is headquartered in Antioch, Tennessee.

Stock Market Value: $7.66 billion ($30.15 per share)

Activist: Ananym Capital ManagementOwnership: 0.39%

Average Cost: n/a

Activist Commentary: Ananym Capital Management is a New York-based activist investment firm which launched on Sept. 3, 2024, and is run by Charlie Penner (a former partner at JANA Partners and head of shareholder activism at Engine No. 1) and Alex Silver (a former partner and investment committee member at P2 Capital Partners). Ananym looks for high quality but undervalued companies, regardless of industry. They would prefer to work amicably with their portfolio companies but are willing to launch a proxy fight as a last resort. According to their most recent 13F filing, they manage $260 million across 10 positions.

What's happeningOn Oct. 21, Ananym Capital called on LKQ to divest its European operations and refocus on its North American business.

Behind the scenesLKQ is a leading distributor of aftermarket vehicle parts. Its core North America segment (40% of revenue and 55% of earnings before interest, taxes, depreciation and amortization) primarily supplies aftermarket collision parts, such as mirrors and bumpers.

The Europe segment (47% of revenue/38% of EBITDA) primarily supplies mechanical and suspension products but contains a wide variety of other replacement and maintenance products. Although the European business is slightly larger by revenue, the North American business has significantly higher margins and a much larger market share compared with its peers.

Lastly, the specialty segment (13% of revenue/7% of EBITDA) provides aftermarket parts for the RV market. Originally just a U.S. aftermarket parts business, the company began aggressively pursuing acquisitions in Europe starting in 2011, shifting from a focus on recycled parts consolidation to building and integrating a European footprint.

Moreover, these two businesses are not nearly as similar as they sound, in North America they do primarily aftermarket collision parts like mirrors and bumpers and in Europe, it's primarily mechanical suspension and things under the hood.

LKQ is no stranger to shareholder activism. In September 2019, when the stock was trading at $27 per share, ValueAct Capital engaged the company and settled for a board seat for one of its partners. Through this campaign, ValueAct was able to usher in a new wave of operational discipline, where instead of focusing on European M&A, LKQ paused large acquisitions and shifted its focus to growing the company's free cash flow and executing buybacks at an attractive discount.

The results of this campaign speak for themselves, as LKQ's share price rose to over $60 during ValueAct's campaign, giving them an 86.39% return on their investment versus 16.15% for the Russell 2000. However, following ValueAct's exit, LKQ returned to its old ways, shifting their focus back to M&A, and the stock had subsequently declined more than 25% by February 2025, when two new activists entered the stock.

In an uninspired campaign and settlement, those activists quickly settled for two board seats for independent directors and the stock has declined by 20% in the eight months since while the Russell 2000 has been up more than 7% during the same time.

Now with the stock just slightly higher than it was in 2019 when ValueAct engaged, a third activist has entered to take over where ValueAct had left off, calling on LKQ to divest its European operations and refocus on its North American business.

LKQ has always been a company that has benefited from simplification and harmed by complexity – and Ananym's plan seems to align with this approach: (i) halt major M&A, (i) divest the European business and other non-core assets, and (iii) use the proceeds to fund buybacks and reinvest in organic growth in the core NA segment.

Operationally, there are several benefits to Ananym's plan. While the U.S. functions as a single market with consistent regulations, Europe is a series of nation states each with their own regulatory framework, making integration far more complex. This creates meaningful execution risks, exemplified by the company still needing to integrate more than 20 ERP systems in 18 different countries.

Not only would divesting Europe leave the company with a higher margin business with a much larger relative market share, but it would also allow management to devote all their time and resources to North America. The alternative is to continue to focus a disproportionate amount of time on integrating all the European acquisitions across the different European countries all from their headquarters in Chicago and Nashville.

The opportunity here is also clear from a valuation perspective. Industrial distribution peers typically trade at mid-teens or higher EBITDA multiples, while LKQ currently trades at 7.3x forward EBITDA. Not only is this a discount to the market, but to its historical levels, as even in its messy conglomerate form, LKQ has still traded on a 10-year historical average of 10x EBITDA.

The European business could potentially be sold at an 8 to 9x multiple, but a sale even at the company's current multiple would be beneficial to unlocking value in the North American business, which could re-rate to its historical multiple of 10x EBITDA.

The proceeds from such a sale could enable LKQ to repurchase up to 40% of its outstanding shares, which, when combined with the re-rating of NA, could easily translate to more than 60% upside from the company's current share price.

While strategics with similar models, such as O'Reilly, AutoZone, and Genuine Parts, may find the European business appealing, strategics generally prefer clean businesses and this is far from that.

Private equity, on the other hand, feasts on these types of projects, using their operational and restructuring expertise and flexibility of being out of the public eye to unlock these complex assets overtime in a way that is more difficult for public companies to address.

In its short history, Ananym has established a reputation for striving to work amicably with management to create value for shareholders, and this situation appears to be no different. The fund has been largely complimentary of LKQ CEO Justin Jude who was named to the position in July 2024 and has his roots in the North American business. Under his short leadership, the company has already taken steps in the right direction — announcing plans to repurchase 14% of outstanding shares and divesting non-core assets such as its self-service salvage business that was sold in August to private equity. It has also signaled that its specialty business is on the market and it's expected to be sold in the near term. However, Jude seems to be a little more attached to the European business than these other businesses. Persuading him to divest Europe may take a little more time.

If we learned anything from the previous activist campaigns at LKQ, this company needs a financially astute shareholder representative, not an independent industry executive. They do not need someone to help them with operations, they need someone to help them financially model, evaluate and potentially execute strategic options and work with the board to arrive at what is best for shareholders.

Given Ananym's reputation as an amicable activist and their constructive relationship with Jude thus far, we think this is a perfect opportunity to put an Ananym representative on the board like Alex Silver who has extensive financial and private equity experience and brings a team of analysts ready to model available opportunities.

Ken Squire is the founder and president of 13D Monitor, an institutional research service on shareholder activism, and the founder and portfolio manager of the 13D Activist Fund, a mutual fund that invests in a portfolio of activist investments.

SAN FRANCISCO, Dec. 20, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in James Hardie Industries plc (NYSE: JHX) as the December 23, 2025, lead plaintiff deadline approaches in a pending securities class action against James Hardie and certain of its key executives.

The litigation alleges that James Hardie senior management misled investors by touting “robust” and “normal” inventory levels, while allegedly aware that channel partners were aggressively destocking as early as April 2025. When this alleged deception was purportedly disclosed on August 20, 2025, it immediately caused a 34% stock collapse and was followed by the abrupt November 17 resignation of CFO Rachel Wilson.

Hagens Berman, which is investigating the claims in the pending litigation, urges investors with substantial losses to submit their information now.

DEEPER DIVE: Read Hagens Berman's latest blog post on James Hardie's alleged inventory deception, Alleged Inventory Deception: Investors Claim James Hardie Concealed Weak Demand, or view our latest video summary of the allegations: www.youtube.com/watch?v=5hXU4zX9asY

“Consistent with the complaint’s allegations, we are investigating whether the purported strength in the North American segment was actually the result of inventory loading,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation in this matter.

Class Action Suit Alleges Inventory Loading

Alleged Deceptive Inventory Statements: The lawsuit alleges that despite witnessing North America Fiber Cement customers destocking inventory as early as April and early May 2025, the defendants issued numerous false assurances that the segment remained strong and expressly denied that destocking was occurring.Concealment of Inventory Loading: Investors were allegedly kept in the dark regarding inventory loading by channel partners. The complaint alleges these practices were concealed while the company emphasized sustainable customer demand.
The August 2025 Disclosure: On August 19, 2025, James Hardie revealed that sales in its critical North America Fiber Cement segment had declined by 12% due to the customer destocking first identified by defendants months earlier.
34% Market Correction: Following this disclosure, the price of James Hardie common stock plummeted by over 34%, resulting in significant financial losses for shareholders. Next Steps for James Hardie (JHX) Investors:

Investors who purchased James Hardie stock (JHX) between May 20, 2025, and August 18, 2025, and suffered substantial losses, are encouraged to contact Hagens Berman immediately to discuss their legal options and potential appointment as Lead Plaintiff.

TO SUBMIT YOUR JAMES HARDIE (JHX) LOSSES NOW, PLEASE USE THE SECURE FORM BELOW:

Submit your JHX losses nowContact: Reed Kathrein at 844-916-0895 or email [email protected] To read more about the issue facing JHX investors, visit, https://www.hbsslaw.com/cases/james-hardie-industries-plc-jhx-securities-class-action

Whistleblowers: Persons with non-public information regarding James Hardie should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contact:
Reed Kathrein, 844-916-0895